明确以模拟目标试验为目的的研究中入选资格、随访开始与治疗分配时间错位处理方法的综述
该研究分析199项明确模拟目标试验的观察性研究,评估入选资格、随访开始与治疗分配三个时间点的对齐情况及处理方法。181项报告三个时间点,其中93项(51%)对齐,88项(49%)存在错位;错位研究中29项使用分析方法校正,59项未处理错位,其中46项(78%)可采用低成本调整。
要点
- 199项模拟目标试验研究中,181项报告三个关键时间点,93项(51%)时间对齐。
- 88项存在时间错位,其中29项使用克隆-删失-加权等方法校正。
- 59项未处理错位的研究中,46项(78%)可采用低成本调整减少偏倚。
核心结论
- 约半数明确模拟目标试验的研究通过设计或方法实现入选资格、随访开始与治疗分配时间对齐。
- 存在时间错位的研究中约67%未在分析中处理,其中78%可采用低成本调整减少偏倚。
研究设计与样本
- 分析先前Hansford等系统综述中识别的199项明确模拟目标试验的研究。
- 由两名评价者提取入选资格、随访开始和治疗分配时间点及用于生成对齐或处理错位的方法。
主要发现
- 199项研究中181项(91%)报告了入选资格、随访开始和治疗分配时间点。
- 181项中93项(51%)三个时间点对齐:73项未使用特定方法,18项模拟一系列目标试验,2项使用其他方法生成对齐。
- 181项中88项(49%)时间点错位,其中29项在分析中校正:24项使用克隆、删失和加权方法,4项随机分配早期事件患者,1项随机分配所有参与者并在偏离时删失。
- 88项错位研究中59项(67%)未使用任何方法处理错位,其中46项(78%)本可采用低成本调整。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Real world evidence based on observational data from cohorts, registries, and health-care databases are increasingly used to assess the effectiveness of therapeutic interventions, often using the target trial emulation framework. One challenge when analyzing observational data are risks of biases due to misalignment of times of eligibility, start of follow-up, and treatment assignment. We aimed to describe the methods used to generate alignment or to account for misalignment in studies explicitly aimed at emulating target trials, and to estimate the proportion of studies for which a low-cost change would limit the risk of biases associated with misalignment of the times. STUDY DESIGN AND SETTING: We analyzed 199 studies explicitly aiming at emulating a target trial identified in a previous systematic review from Hansford et al. Two reviewers extracted the times of eligibility, start of follow-up, and treatment assignment and the methods used by authors to generate alignment or to account for misalignment of time points. RESULTS: Out of the 199 studies, 181 (91%) reported the times of eligibility, start of follow-up, and treatment assignment. All time points were aligned for 93/181 (51%), with 73 using no specific method, 18 emulating a sequence of target trials, and 2 using other methods to generate alignment. In contrast, 88/181 (49%) studies had misalignment of time points, of which 29 used a method to correct for misalignment during analysis (24 studies used a cloning, censoring, and weighting approach; 4 randomly allocated patients with early events; and 1 randomly allocated all participants to the study groups with subsequent censoring when they deviated from the allocated intervention). Out of 59/88 (67%) studies that did not use any method to address nonalignment, 46/59 (78%) could have applied low-cost changes to account for misalignment. CONCLUSION: Approximately, half of the studies explicitly aiming to emulate a target trial had alignment of times of eligibility, start of follow-up, and treatment assignment, either by design or using a method generating alignment. Among studies with misalignment, about 67% did not account for it in the analysis among which 78% could have applied low-cost changes to reduce bias. PLAIN LANGUAGE SUMMARY: Researchers increasingly use real-world evidence from sources like routinely collected or claims data to assess the efficacy and safety of therapeutic interventions (medications, surgery, physiotherapy, etc). To prevent design errors when analyzing these data, researchers follow a framework called "target trial emulation". A crucial aspect of this framework is to ensure that three key time points of the study are aligned during analysis: the times at which 1) participants in the database are assessed for eligibility in the study (ie, when do we choose to include them or not in the analysis), 2) their follow-up begin, and 3) they are assigned to a treatment group. If these time points are misaligned, the study results can be biased. Here, we reviewed 199 published studies that explicitly aimed to emulate a target trial identified in a previous systematic review by Hansford et al. We found that about half of them had alignment between of times of eligibility, treatment assignment, and follow-up. In the other half, there was misalignment but one-third used specific methods to correct for this problem. Many studies that aim to emulate a trial may have issues in alignment of key time points, which can compromise the validity of their findings. Most of these issues could be corrected with straightforward adjustments.
引用
- McIntyre M, Yaacoub S, Perrodeau E, et al. Review of methods to deal with the misalignment of times of eligibility, start of follow-up, and treatment assignment in studies explicitly aimed at emulating target trials. J Clin Epidemiol. 2025. PMID: 40639692. doi:10.1016/j.jclinepi.2025.111898
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。